Wednesday, September 01, 2021 7:32:17 PM
Second risk low was nites issued …. Again with the latest 8K …… risk mitigated. Yes we so have some old notes if Dr Koos fails to re-negotiate etc….. we might end up getting inflow….. Risk accepted.
The last risk I see is if we do not merge or get bought out we might end up with an R/S …….. as we might need cash flow to finance ……..again very low risk. Risk accepted. Rationale - we got to PINK. There is a reason why we are pink - big whales will only participate with a transparent, reporting company.
The technology / patents RGBP is holding is worth more than the last 2 upper risks mentioned……. IMHO we are very golden here….. rare opportunity to get in at this prices……… risk vs reward is great. Weeks/ months i do not care worry. This is my retirement vehicle. Cheers GL.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM

